Skip to main content

Table 2 Melanoma characteristics at baseline

From: Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study

 

ICI treated (n = 289)

Non-ICI treated (n = 357)

p-value

Melanoma characteristics

 Breslow in mm (IQR)

2.7 (1.5—4.7)

2.8 (2—4.2)

0.829a

 Ulceration (%)

43.0% (108)

38.4% (129)

0.257b

Histologic subtype

 SSM (%)

43.0

41.0

 

 Nodular (%)

29.6

34.0

 

 LMM (%)

8.1

4.9

 

 ALM (%)

4.5

5.3

 

 Other (%)

14.8

14.8

 

AJCC 8th Edition Stage at baseline

 IIA

0

137

 

 IIB

1

56

 

 IIC

3

31

 

 IIIA

2

21

 

 IIIB

52

55

 

 IIIC or IIID

94

48

 

 IV

137

9

 
  1. aMann–Whitney U test
  2. bChi-squared test
  3. SSM Superficial spreading melanoma, LMM Lentigo maligna melanoma, ALMAcral lentiginous melanoma, AJCC American Joint Committee on Cancer
Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us